Pacira Pharmaceuticals reported $1.73B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 56.13M 15.84M
Aerie Pharmaceuticals AERI:US $ 385.34M 10.21M
Amerisourcebergen ABC:US $ 57173.63M 134.52M
Astellas Pharma 4503:JP Y 2481843M 149448M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Cara Therapeutics CARA:US $ 226.57M 2.71M
Coherus Biosciences CHRS:US $ 546M 47.38M
Depomed DEPO:US $ 321.98M 17.16M
Endo International Ordinary Shares ENDP:US $ 6362.26M 2084.95M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Horizon Pharma HZNP:US $ 8853.47M 113.14M
Ironwood Pharmaceuticals IRWD:US $ 975.69M 107.69M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Lannett LCI:US $ 572.31M 22.63M
Ligand Pharmaceuticals LGND:US $ 1076.29M 28.9M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Perrigo Ordinary Shares PRGO:US $ 10919.6M 530.1M
Revance Therapeutics RVNC:US $ 561.88M 77.66M
Supernus Pharmaceuticals SUPN:US $ 1694.97M 55.46M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
Xeris Pharmaceuticals Inc XERS:US $ 318.62M 19.01M
Xoma XOMA:US $ 154.22M 4.94M
Zoetis ZTS:US $ 13770M 90M